ARCHIVES

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

This article is from The Cancer Letter archive.

Vol. 33 No. 45 | December 7, 2007

Download PDF Visit The Full Archive

Related Articles

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

August 1, 1997

Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida

January 10, 2014

AACI Leaders Regret “Unfortunate Rhetoric,” Pledge Support To Broder

August 11, 1989

Bepler To Lead Karmanos Cancer Institute

January 29, 2010

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

January 30, 2009

What Is and Isn’t a Crime in Texas: CPRIT Official Indicted For Skipping Peer Review

December 13, 2013